Crystal Structures of PI3Kα Complexed with PI103 and Its Derivatives: New Directions for Inhibitors Design

Area of Science:

• Biochemistry
• Molecular Biology
• Cancer Research

Background:

• The phosphatidylinositol 3-kinase (PI3K) pathway is crucial for cell functions.
• Hyperactivated PI3K signaling is implicated in numerous human cancers.
• PI3K represents a significant therapeutic target in oncology.

Purpose of the Study:

• To elucidate the molecular interactions of PI3Kα inhibitors through crystal structure determination.
• To provide a structural basis for the design of novel and effective PI3Kα inhibitors.

Main Methods:

• X-ray crystallography was employed to determine the structures of human PI3Kα complexed with inhibitors PI103 and 9d.
• Structure-based analysis was performed to identify key molecular interactions and binding determinants.

Main Results:

• Crystal structures revealed specific interactions between PI3Kα and inhibitors PI103 and 9d.
• Substitution at the R1 position of PI103 enhanced binding affinity by forming a hydrogen bond with Lys802.
• The flexibility of Lys802 was identified as a critical factor for accommodating modifications and enhancing inhibitor design.

Conclusions:

• The determined crystal structures offer a molecular foundation for understanding PI3Kα inhibitor binding.
• Lys802 plays a pivotal role in achieving strong and specific interactions with PI3Kα inhibitors.
• These findings facilitate the rational design of next-generation PI3Kα inhibitors for cancer treatment.